BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 28820433)

  • 1. Targeting Persistent Human Papillomavirus Infection.
    Shanmugasundaram S; You J
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28820433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in vaccination against human papillomavirus-mediated cervical cancer.
    McKee SJ; Bergot AS; Leggatt GR
    Rev Med Virol; 2015 Mar; 25 Suppl 1():54-71. PubMed ID: 25752816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current strategies against persistent human papillomavirus infection (Review).
    Liu Y; Li H; Pi R; Yang Y; Zhao X; Qi X
    Int J Oncol; 2019 Sep; 55(3):570-584. PubMed ID: 31364734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in Understanding Carcinogenetic Mechanisms of the Human Papillomavirus and Vaccines Based on Virus-like Particles].
    Zhao Z; Wang L; Ma B
    Bing Du Xue Bao; 2015 Mar; 31(2):180-6. PubMed ID: 26164945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
    Bhat P; Mattarollo SR; Gosmann C; Frazer IH; Leggatt GR
    Immunol Rev; 2011 Jan; 239(1):85-98. PubMed ID: 21198666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines and immunization against human papillomavirus.
    Christensen ND; Budgeon LR
    Curr Probl Dermatol; 2014; 45():252-64. PubMed ID: 24643192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus: current status and issues of vaccination.
    Malik H; Khan FH; Ahsan H
    Arch Virol; 2014 Feb; 159(2):199-205. PubMed ID: 24022639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with Human Papillomavirus 16 L1+E2 Chimeric Capsomers Elicits Cellular Immune Response and Antitumor Activity in a Mouse Model.
    López-Toledo G; Schädlich L; Alonso-Castro ÁJ; Monroy-García A; García-Rocha R; Guido MC; Gissmann L; García-Carrancá A
    Viral Immunol; 2016 Jun; 29(5):276-87. PubMed ID: 27058179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S; Alain S; Denis F
    Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA vaccines for cervical cancer: from bench to bedside.
    Hung CF; Monie A; Alvarez RD; Wu TC
    Exp Mol Med; 2007 Dec; 39(6):679-89. PubMed ID: 18160838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How will HPV vaccines affect cervical cancer?
    Roden R; Wu TC
    Nat Rev Cancer; 2006 Oct; 6(10):753-63. PubMed ID: 16990853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a review.
    Ault KA
    Obstet Gynecol Surv; 2006 Jun; 61(6 Suppl 1):S26-31. PubMed ID: 16729901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired immune response to oncogenic human papillomavirus associated with prophylactic cervical cancer vaccines.
    Einstein MH
    Cancer Immunol Immunother; 2008 Apr; 57(4):443-51. PubMed ID: 18157723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for human papillomavirus therapeutic vaccines and other therapies based on the E6 and E7 oncogenes.
    Govan VA
    Ann N Y Acad Sci; 2005 Nov; 1056():328-43. PubMed ID: 16387699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
    Mahdavi A; Monk BJ
    Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papilloma vaccination to adolescents.
    Levavi H
    Pediatr Endocrinol Rev; 2010 Sep; 8(1):2-5. PubMed ID: 21037538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus infection: an old disease, a new vaccine.
    Giles M; Garland S
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):180-5. PubMed ID: 16704468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus vaccines--immune responses.
    Stanley M; Pinto LA; Trimble C
    Vaccine; 2012 Nov; 30 Suppl 5():F83-7. PubMed ID: 23199968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
    Wheeler CM
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):519-36; vii. PubMed ID: 19061814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.